section name header

Pronunciation ⬇

dye-METH-uhl sul-FOK-side

Classifications ⬆ ⬇

Therapeutic Classification: none assigned

Indications ⬆ ⬇

REMS


Unlabeled Use:
  • Topical Prevention of extravasation injury from antineoplastic agents.

Action ⬆ ⬇

  • Stimulates bladder afferent pathways, causing release of nitrogen oxide from afferent neurons which controls lower urinary tract function. Also has anti-inflammatory, anti-ischemic analgesic, and vasodilatory properties.
Therapeutic effects:
  • Improved symptoms of interstitial cystitis.
  • Prevention of tissue necrosis from extravasation injuries.

Pharmacokinetics ⬆ ⬇

Absorption: Easily penetrates the skin.

Distribution: Widely distributed to tissues

Metabolism/Excretion: Metabolized to dimethyl sulfone and dimethyl sulfide.

Half-Life: Unknown.

Time/Action Profile ⬆ ⬇

ROUTEONSETPEAKDURATION
Topical, Intravesicularunknown4 hrunknown



Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

Derm: dry skin, pruritus

GI: diarrhea, nausea, vomiting

GU: bladder discomfort

Hemat: eosinophilia

Neuro: dizziness, headache, sedation

Misc: garlic-like breath/body odor

Interactions ⬆ ⬇

Drug-drug:

Route/Dosage ⬆ ⬇

Interstitial Cystitis

Extravasation

Availability ⬆ ⬇

Assessment ⬆ ⬇

Lab Test Considerations:

Implementation ⬆ ⬇

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

US Brand Names ⬆

Rimso-50